Pediatric systemic lupus erythematosus demographic and disease characteristics at the time of assessment of anti-Müllerian hormone (AMH).
| Pt | Age, yrs | Disease Duration, yrs | Regular Menses, Yes/No | SLEDAI | SDI | Major SLE Manifestations | No. CYC Cycles/Total Dose, g | Years Since CYC | AMH, ng/ml |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 15 | 2.7 | Y | 2 | 0 | PLT | 1.69 | ||
| 2 | 20 | 6.6 | Y | 30 | 2 | LN IV | 5.78 | ||
| 3 | 16 | 0.5 | Y | 6 | 0 | 2.62 | |||
| 4 | 17 | 2.8 | Y | 8 | 0 | 1.11 | |||
| 5 | 20 | 2.2 | N | 2 | 0 | Pericarditis | 2.35 | ||
| 6 | 20 | 3.2 | Y | 4 | 0 | LN IV | 6/7.2 | 2.5 | 0.99 |
| 7 | 21 | 2.1 | N* | 0 | 0 | LN III/V | 2.01 | ||
| 8 | 18 | 9.8 | Y | 6 | 0 | LN IV/V, LN III/V, LSE | 9/** | 7.5 | 0.83 |
| 9 | 24 | 9.7 | Y | 2 | 1 | LN IV, PHTN | 7/** | 8.6 | 0.75 |
| 10 | 18 | 6.2 | Y | 20 | 2 | LN (no biopsy), CVA, NPSLE | 7/10 | 3.5 | 0.22 |
| 11 | 18 | 1.1 | Y | 7 | 0 | PLT | 1.65 | ||
| 12 | 19 | 5.9 | N | 4 | 0 | 2.27 | |||
| 13 | 19 | 3.3 | Y | 3 | 0 | 1.55 | |||
| 14 | 16 | 3.6 | Y | 8 | 3 | Vision loss, NPSLE, CVA | 16/25.5 | 0.4 | 0.09 |
| 15 | 20 | 8.8 | Y | 8 | 2 | NPSLE, PLT | 7/6.7 | 7.3 | 3.69 |
| 16 | 18 | 0.7 | Y | 10 | 0 | 2.48 | |||
| 17 | 18 | 8.3 | Y | 0 | 0 | 1.84 | |||
| 18 | 22 | 6.6 | Y | 2 | 0 | 4.15 | |||
| 19 | 19 | 7.5 | N | 8 | 1 | LN III, DVT | 0.6 | ||
| 20 | 15 | 8.1 | Y | 2 | 1 | LN V, DVT | 1.49 | ||
| 21 | 17 | 2.6 | Y | 4 | 0 | 1.94 | |||
| 22 | 21 | 3.3 | Y | 4 | 0 | PLT | 2.15 | ||
| 23 | 20 | 2.4 | Y | 0 | 0 | 3.83 |
↵* Taking Depo-Provera for contraception.
↵** Total cyclophosphamide (CYC) dosage could not be accurately calculated because CYC treatment started before transfer of care to our institution. CVA: cerebrovascular accident; DVT: deep vein thrombosis; LN: lupus nephritis; LSE: Libman-Sacks endocarditis; NPSLE: neuropsychiatric systemic lupus erythematosus; PHTN: pulmonary hypertension; PLT: significant thrombocytopenia; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; SDI: Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index.